Close Menu

The announcement earlier this week that Pfizer and BioNTech's SARS-CoV-2 vaccine appears effective may bode well for other, similar vaccines, the Verge reports

"It's extremely encouraging, in my view, not only for the Pfizer vaccine, but broadly speaking for the platform," the University of Colorado's Ross Kedl tells it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.